2023 Registration is now open!

  • Home
  • Keynote Speakers
  • Program
  • Abstracts
  • Registration
  • Accommodations
  • Sponsors
  • COVID
  • Contact
  • More
    • Home
    • Keynote Speakers
    • Program
    • Abstracts
    • Registration
    • Accommodations
    • Sponsors
    • COVID
    • Contact

2023 Registration is now open!

  • Home
  • Keynote Speakers
  • Program
  • Abstracts
  • Registration
  • Accommodations
  • Sponsors
  • COVID
  • Contact

2023 Program coming soon!

Last year's 2022 Program

For additional Information please email mcdermottmi@tamu.edu

  

Sunday, November 13th, 2022

4:00 pm - 5:30 pm  Arrival and Registration

5:30 pm – 6:30 pm  Welcome Reception (Pisgah & Pilot)

6:30 pm - 7:30 pm  Dinner (Pisgah & Pilot)

7:45 pm – 7:55 pm  Welcome and Opening Remarks (Mitchell & Roan)

Jamie Sturgill, University of Kentucky

8:00 pm – 9:00 pm Keynote Presentation 

Alex Toker, Ph.D., Harvard Medical School and Beth Israel Deaconess Medical Center

9:00 pm – 11:00 pm  Social Time and Preliminary Poster Viewing (Pisgah & Pilot)


Monday, November 14th, 2022

8:00 am - 9:00 am Breakfast (Pisgah & Pilot)

9:00 am – 10:15 am Oral Session I (Mitchell & Roan) Lipids in Cancer

Session Chairs: Prasanna Iyer and Stocko Stamatikos

9:00 am IRF8 regulates the intrinsic ferroptosis to control tumor cell vulnerability to cytotoxic T lymphocytes. Dakota Poschel. Medical College of Georgia. 

9:15 am  Cellular glycosphingolipid imbalance modulates EMT in cancer cells. Laura Clark. Virginia Commonwealth University.

9:30 am  INPP4B signaling controls cancer progression through the regulation of lysosomal  functions. Lenny Salmena. University of Toronto. 

9:45 am Co-targeting Glucosylceramide Synthase and Serine Palmitoyl Transferase for Colon Cancer Therapy. Allie Strauss. Virginia Commonwealth University. 

10:00 am  Understanding the function and mechanism of mammalian START-like PITPNC1 in relation to cancer. Adrija Pathak. Texas A&M University. 


10:15 am – 10:30 am  Break


10:30 am – 11:30 pm  Oral Session II (Mitchell & Roan) Lipids in Diabetes and Metabolic Disease

Session Chairs: Salim El-Amouri and David Montefusco

10:30 am Spatial metabolomics of endotoxin-induced kidney injury in diabetes. Tom DeLuca. Indiana University 

10:45 am Conditional Reduction of iPLA2β in Macrophages Protects from Type 1 Diabetes Pathogenesis and Incidence in NOD mice. Abdulaziz Almutairi. University of Alabama at Birmingham. 

11:00 am Inhibition of ceramide rich platform formation via anti-ceramide immunotherapy for diabetic retinopathy. Arjun Singh. Memorial Sloan Kettering Cancer Center. 

11:15 am T Lymphocytes with Reduced iPLA2β Expression Delays Type I Diabetes Development in NOD Female Mice. Tayleur White. University of Alabama at Birmingham. 


11:30 am – 12:30 pm  Keynote Presentation 

Alyssa Hasty, Ph.D., Vanderbilt University School of Medicine


12:30 pm – 1:30 pm  Lunch (Pisgah & Pilot)

1:30 pm – 4:00 pm Free time

4:00 pm - 6:00 pm Poster Session (Pisgah & Pilot) and Cocktail Hour

Poster Session Chairs: Lenny Salmena and Lokman Hossen


6:00 pm – 6:15 pm  Awards ceremony (Mitchell & Roan)

6:15 pm – 6:30 pm Presentation of the Lina Obeid Young Scientist Award 

Ashley Cowart, Ph.D., Virginia Commonwealth University


6:30 pm – 7:00 pm Lina Obeid Young Scientist Award Lecture

7:00 pm – 8:00 pm SERLC Banquet at the Expo Center

8:00 pm – 11:00 pm Live Bluegrass Entertainment and Square Dancing at the Expo Center


Tuesday, November 15th, 2022

8:00 am - 9:00 am Breakfast (Pisgah & Pilot)

9:00 am – 10:15 am Oral Session III (Mitchell & Roan) Lipids in Hepatic Disease

Session chairs: Arjun Singh and Yao Zhang

9:00 am Overexpression of ORMDL3 confers sexual dimorphism in diet-induced non-alcoholic fatty liver disease. Ryan Brown. Virginia Commonwealth University. 

9:15 am Regulation of nSMase2 in AML-12 cells, a novel model of hepatic steatosis. Salim El-Amouri. University of Kentucky

9:30 am Novel role for Serine Palmitoyltransferase 3 (SPTLC3) in liver mitochondrial dysfunction. Maryam Jamil. Virginia Commonwealth University. 

9:45 am  Investigating how Signaling Lipids Regulate the Structure and Function of Liver Receptor Homolog-1. James Poland. Vanderbilt University.  

10:00 am Atypical SPTLC3-Generated Sphingolipids as Regulators of Hepatic Glucose Production. David Montefusco. Virginia Commonwealth University. 


10:15 am – 10:45 am  Break - please make sure you are checked out of the hotel at this time. 


10:45 am – 12:00 pm  Oral Session IV (Mitchell & Roan) Lipids in Inflammation

Session chairs: Ryan Brown and Tom DeLuca

10:45 am Generation of exhausted monocytes memory and underlying mechanisms. Yajun Wu. Virginia Tech

11:00 am Ceramide as a novel biomarker in acute respiratory distress syndrome. Luke McKinney. University of Kentucky. 

11:15 am Phosphatidylinositol-4-Phosphate regulates the formation of dense granules in Toxoplasma gondii. Angela Arabiotorre. Texas A&M University

11:30 am Sphingolipids in exhaled breath condensate of patients with pulmonary disease. Alex Williams. University of Kentucky

11:45 am Ceramide Synthase 6 Regulates Mouse Brain Metabolome. Madeline Hall. University of North Carolina. 

12:00 pm – 12:30 pm Closing Remarks and SERLC Business meeting to plan for 2023 Conference. 

12:30 pm – 1:30 pm Lunch (Pisgah & Pilot)

1:30 pm  56th SERLC adjournedT

Copyright © 2019 Southeastern Regional Lipid Conference  - All Rights Reserved.

Powered by Avanti Marketing